|

Novel Serum Markers for Monitoring Response to Anti-Cancer Therapy

RECRUITINGSponsored by Stanford University
Actively Recruiting
SponsorStanford University
Started2002-01
Est. completion2032-01
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT00349830

Summary

The purpose of this study is to measure the levels of serum proteins and other biomarkers in cancer patients and in patients suspected of having cancer. We believe that some of these markers may be useful for confirming the diagnosis or for selecting patients for specific types of cancer therapies. These markers may also help to predict response to therapy, relapse after therapy, and survival after therapy.

Eligibility

Age: 18 Years+Healthy volunteers accepted
1. Age \> or = 18; for the samples collected under the NIH grant, no subjects below the age of 20 will be enrolled.
2. Prior diagnosis of cancer or suspected of having cancer
3. Karnofsky performance status of greater than 70
4. Standard pretreatment evaluation
5. Signed Stanford University Human Subjects Committee consent

Conditions3

CancerCarcinomas (Including Squamous Cell and Adenocarcinoma)Neoplasms

Locations1 site

Stanford University School of Medicine
Stanford, California, 94305
Rene Bonilla650-498-7703rbonilla@stanford.edu

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.